Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study

✍ Scribed by Fowler, N.; Kahl, B. S.; Lee, P.; Matous, J. V.; Cashen, A. F.; Jacobs, S. A.; Letzer, J.; Amin, B.; Williams, M. E.; Smith, S.; Saleh, A.; Rosen, P.; Shi, H.; Parasuraman, S.; Cheson, B. D.

• Book ID: 127158754
• Publisher: American Society of Clinical Oncology
• Year: 2011
• Tongue: English
• Weight: 215 KB
• Volume: 29
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/jco.2010.32.1844